Statin use and ocular inflammatory disease risk.

Following adjustment for diabetes, lipid metabolism disorders, hypertension, cardiovascular disease, cerebrovascular disease, and arterial disease, a twofold reduction in the risk of OID development was associated with any history of statin use (OR, 0.50; 95% CI, 0.20 to 1.23), although this did not reach statistical significance ( p = 0.13).

also in 111,027 other papers

A twofold reduction in risk, with a p value trending toward significance, may be statistically insignificant, but still clinically relevant.

also in 580 other papers